Norah Terrault, MD, MPH

Professor of Medicine, Chief, Division of GI and Liver: Neil Kaplowitz Chair in Liver Diseases

Image of Norah Terrault, MD, MPH
Is this your profile? Click to edit

Overview

Dr. Norah Terrault is Professor of Medicine and Chief of Gastroenterology and Liver Diseases and Neil Kaplowitz Endowed Chair in Liver Diseases Research. She received her MD from the University of Alberta and completed fellowships in Internal Medicine and Gastroenterology at the University of Toronto and a Masters in Public Health at the University of California at Berkeley. Dr. Terrault has focused her clinical and research activities on viral hepatitis and steatotic liver disease (metabolic and alcohol-associated), especially in special populations including those with cirrhosis and those with transplants. In addition to multiple clinical trials related to preventing and treating chronic hepatitis viral hepatitis and metabolic steatotic liver disease, Dr. Terrault has been PI on multiple NIH-funded studies, including the current NIDDK-supported Liver Cirrhosis Network and nonalcoholic steatohepatitis clinical research network (NASH CRN). She has authored more than 450 peer-reviewed manuscripts, editorials, and invited reviews as well as co-authoring US national guidelines for treatment of chronic hepatitis B and C and alcohol-associated liver disease. She is past associate editor for Hepatology and deputy editor for Liver Transplantation and co-edited Zakim and Boyer’s textbook in hepatology. Dr. Terrault is currently serving as the president of the American Association for the Study of Liver Diseases (AASLD). She is the founder of USC Project ECHO, a multifaceted program to train and support primary care physicians in California to care for patients with viral hepatitis. She has a long history of mentoring fellows and junior faculty in clinical research and is passionate about creating research support and opportunities for the next generation of GI/Hepatology investigators.

Research Funding

  • 1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
    NIH · R01AA030960 · Aug 1, 2023 – Jul 31, 2030 · Role: Principal Investigator
  • Translational Research Training in Hepatology
    NIH · T32DK127977 · Jul 1, 2022 – Jun 30, 2027 · Role: Principal Investigator
  • USC Cirrhosis Clinical Center
    NIH · U01DK130197 · Sep 22, 2021 – Jul 31, 2027 · Role: Principal Investigator
  • Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
    NIH · R01MD015971 · Jan 1, 2021 – Nov 30, 2026 · Role: Co-Principal Investigator
  • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    NIH · U01DK082944 · Sep 30, 2008 – May 31, 2021 · Role: Co-Principal Investigator
  • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
    NIH · U01DK061738 · Jun 15, 2002 – Jun 30, 2027 · Role: Principal Investigator

Publications

  • Baseline characteristics of a prospective, multi-center study on the natural history of compensated cirrhosis: the Liver Cirrhosis Network. Am J Gastroenterol. 2026 Sep 18.. View in PubMed
  • High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium. Gut. 2026 Sep 18.. View in PubMed
  • Reply to: Correspondence on “Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD”. J Hepatol. 2026 Aug 27.. View in PubMed
  • Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. N Engl J Med. 2026 Jun 25; 394(24):2395-2406.. View in PubMed
  • Steatotic Liver Disease, Clinical Subtypes, and Adverse Perinatal Outcomes: The Prospective Fatty Liver in Pregnancy Study. Clin Gastroenterol Hepatol. 2026 Apr 20.. View in PubMed
  • Metabolic Dysfunction and Alcohol-Associated Steatotic Liver Disease in Women: Epidemiology, Natural History, and Clinical Outcomes. Clin Gastroenterol Hepatol. 2026 Apr 13.. View in PubMed
  • Shared principles within HBV guidelines: aligning clinical approach with differentiated care for global elimination. Lancet Gastroenterol Hepatol. 2026 Jun; 11(6):441-443.. View in PubMed
  • Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort. J Hepatol. 2026 Jul; 85(1):61-70.. View in PubMed
  • Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities. Ann Hepatol. 2026 Mar 11; 31(2):102200.. View in PubMed
  • Sex-Specific Cardiometabolic Profiles and Severity of Liver Fibrosis. JAMA Netw Open. 2026 03 02; 9(3):e260863.. View in PubMed